Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force

Annals of Internal Medicine

Volumn 138, Issue 11, 2003, Pages

  Boustani, Malaz ^a   Peterson, Britt ^a   Hanson, Laura ^a   Harris, Russell ^a   Lohr, Kathleen N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; ESTROGEN; GALANTAMINE; GINKGO BILOBA EXTRACT; NEUROLEPTIC AGENT; NIMODIPINE; RIVASTIGMINE; SELEGILINE; TACRINE;

ALZHEIMER DISEASE; CAREGIVER; CLINICAL TRIAL; COGNITION; DEMENTIA; DIARRHEA; EVIDENCE BASED MEDICINE; HUMAN; NAUSEA; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SCREENING; SIDE EFFECT; TREATMENT OUTCOME; UNITED STATES; VOMITING; WEIGHT REDUCTION; AGED; MASS SCREENING; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT; STANDARD;

AGED; AGED, 80 AND OVER; CAREGIVERS; CHOLINESTERASE INHIBITORS; DEMENTIA; EVIDENCE-BASED MEDICINE; HUMANS; MASS SCREENING; SOCIAL SUPPORT;

EID: 0037844484     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-11-200306030-00015     Document Type: Review

References (119)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Assoc; 1994.
2. Boustani M, Peterson B, Hanson L, Harris R, Krasnov C. Screening for Dementia. A Systematic Evidence Review. Rockville, MD: Agency for Healthcare Research and Quality; 2002. Available at www.ahrq.gov/clinic/uspstfix.htm.
3. Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J, et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology. 1996;46:641-50. [PMID: 8618660]
4. Blacker D, Tanzi RE. The genetics of Alzheimer disease: current status and future prospects. Arch Neurol. 1998;55:294-6. [PMID: 9520001]
5. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46:849-53. [PMID: 2527024]
6. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 1998;55:1217-25. [PMID: 9740116]
7. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-4. [PMID: 9111537]
8. U.S. Office of Technology Assessment. Losing a Million Minds: Confronting the Tragedy of AD and Other Dementias. Washington, DC: U.S. Government Printing Office; 1987.
9. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262:2551-6. [PMID: 2810583]
10. Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol. 1991;134:403-12. [PMID: 1877601]
11. U.S. General Accounting Office. Alzheimer's Disease: Estimates of Prevalence in the United States. Washington, DC: U.S. General Accounting Office; 1998. Publication HEHS 98-16.
12. Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ. 1999;160:S1-15. [PMID: 10410645]
13. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ. 1994;150:899-913. [PMID: 8131123]
14. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337-42. [PMID: 9736873]
15. Brodaty H, Clarke J, Ganguli M, Grek A, Jorm AF, Khachaturian Z, et al. Screening for cognitive impairment in general practice: toward a consensus. Alzheimer Dis Assoc Disord. 1998;12:1-13. [PMID: 9539404]
16. Ernst RL, Hay JW. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health. 1994;84:1261-4. [PMID: 8059882]
17. Dunkin JJ, Anderson-Hanley C. Dementia caregiver burden: a review of the literature and guidelines for assessment and intervention. Neurology. 1998;51: S53-60. [PMID: 9674763]
18. Grafström M, Fratiglioni L, Sandman PO, Winblad B. Health and social consequences for relatives of demented and non-demented elderly. A population-based study. J Clin Epidemiol. 1992;45:861-70. [PMID: 1624968]
19. Schulz R, O'Brien AT, Bookwala J, Fleissner K. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist. 1995;35:771-91. [PMID: 8557205]
20. Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. Natl Vital Stat Rep. 1999;47:1-104. [PMID: 10410536]
21. Gold DP, Reis MF, Markiewicz D, Andres D. When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia. J Am Geriatr Soc. 1995;43:10-6. [PMID: 7806732]
22. Arno PS, Levine C, Memmott MM. The economic value of informal caregiving. Health Aff (Millwood). 1999;18:182-8. [PMID: 10091447]
23. O'Connor DW, Pollitt PA, Hyde JB, Brook CP, Reiss BB, Roth M. Do general practitioners miss dementia in elderly patients? BMJ. 1988;297:1107-10. [PMID: 3143447]
24. Lagaay AM, van der Meij JC, Hijmans W. Validation of medical history taking as part of a population based survey in subjects aged 85 and over. BMJ. 1992;304:1091-2. [PMID: 1586823]
25. Cooper B, Bickel H, Schaufele M. Early development and progression of dementing illness in the elderly: a general-practice based study. Psychol Med. 1996;26:411-9. [PMID: 8685297]
26. Olafsdottir M, Skoog I, Marcusson J. Detection of dementia in primary care: the Linkoping study. Dement Geriatr Cogn Disord. 2000;11:223-9. [PMID: 10867449]
27. Valcour VG, Masaki KH, Curb JD, Blanchette PL. The detection of dementia in the primary care setting. Arch Intern Med. 2000;160:2964-8. [PMID: 11041904]
28. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, VA: International Medical Publishing; 1996:531-40.
29. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-42. [PMID: 11342677]
30. Patterson CJ, Gass DA. Screening for cognitive impairment and dementia in the elderly. Can J Neurol Sci. 2001;28 Suppl 1:S42-51. [PMID: 11237310]
31. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21-35. [PMID: 11306229]
32. Eefsting JA, Boersma F, Van den Brink W, Van Tilburg W. Differences in prevalence of dementia based on community survey and general practitioner recognition. Psychol Med. 1996;26:1223-30. [PMID: 8931168]
33. Sternberg SA, Wolfson C, Baumgarten M. Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging. J Am Geriatr Soc. 2000;48:1430-4. [PMID: 11083319]
34. Petracca G, Teson A, Chemerinski E, Leiguarda R, Starkstein SE. A double-blind placebo-controlled study of domipramine in depressed patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1996;8:270-5. [PMID: 8854297]
35. Auchus AP, Bissey-Black C. Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1997; 9:591-3. [PMID: 9447502]
36. Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry. 1998; 155:1512-20. [PMID: 9812111]
37. Costa PT Jr, Williams TF, Somerfield M, Albert MS, Nutters NM, Folstein MF, et al. Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias. Clinical Practice Guideline no. 19. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996. AHCPR publication no. 97-0702.
38. Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS, et al. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study. Am J Psychiatry. 2000;157: 1686-9. [PMID: 11007727]
39. Jitapunkul S, Lailert C, Worakul P, Srikiatkhachorn A, Ebrahim S. Chula Mental Test: a screening test for elderly people in less developed countries. Int J Geriatr Psychiatry. 1996;11:714-20.
40. McDowell I, Kristjansson B, Hill GB, Hebert R. Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol. 1997;50:377-83. [PMID: 9179095]
41. Lindeboom J, Launer LJ, Schmand BA, Hooyer C, Jonker C. Effects of adjustment on the case-finding potential of cognitive tests. J Clin Epidemiol. 1996;49:691-5. [PMID: 8656232]
42. Law S, Wolfson C. Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease. Br J Psychiatry. 1995; 167:541-4. [PMID: 8829727]
43. Braekhus A, Laake K, Engedal K. A low, 'normal' score on the Mini-Mental State Examination predicts development of dementia after three years. J Am Geriatr Soc. 1995;43:656-61. [PMID: 7775725]
44. Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, et al. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology. 2000;55:1271-8. [PMID: 11087767]
45. Solomon PR, Brush M, Calvo V, Adams F, DeVeaux RD, Pendlebury WW, et al. Identifying dementia in the primary care practice. Int Psychogeriatr. 2000;12:483-93. [PMID: 11263715]
46. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55:1409-15. [PMID: 9823823]
47. Birks J, Flicker L. Selegiline for Alzheimer's disease. Cochrane Database Syst Rev. 2000:CD000442. [PMID: 10796544]
48. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997;336:1216-22. [PMID: 9110909]
49. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000;283:1007-15. [PMID: 10697060]
50. Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 2001;57:605-12. [PMID: 11524467]
51. Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. J Neurol Sci. 2000; 175:124-34. [PMID: 10831773]
52. Williams PS, Rands G, Orrel M, Spector A. Aspirin for vascular dementia. Cochrane Database Syst Rev. 2000:CD001296. [PMID: 11034710]
53. Thompson C, Briggs M. Support for carers of people with Alzheimer's type dementia. Cochrane Database Syst Rev. 2000:CD000454. [PMID: 10796545]
54. Hebert R, Leclerc G, Bravo G, Girouard D, Lefrancois R. Efficacy of a support group programme for caregivers of demented patients in the community: a randomized controlled trial. Arch Gerontol Geriatr. 1994;18:1-14.
55. Hebert R, Girouard D, Leclerc G, Bravo G, Lefrancois R. The impact of a support group programme for care-givers on the institutionalization of demented patients. Arch Gerontol Geriatr. 1995;20:129-34.
56. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial. JAMA. 1996;276:1725-31. [PMID: 8940320]
57. McCurry SM, Logsdon RG, Vitiello MV, Teri L. Successful behavioral treatment for reported sleep problems in elderly caregivers of dementia patients: a controlled study. J Gerontol B Psychol Sci Soc Sci. 1998;53:P122-9. [PMID: 9520929]
58. Marriott A, Donaldson C, Tarrier N, Burns A. Effectiveness of cognitive-behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer's disease. Br J Psychiatry. 2000;176:557-62. [PMID: 10974962]
59. Brodaty H, Gresham M, Luscombe G. The Prince Henry Hospital dementia caregivers' training programme. Int J Geriatr Psychiatry. 1997;12:183-92. [PMID: 9097211]
60. Barberger-Gateau P, Fabrigoule C, Helmer C, Rouch I, Dartigues JF. Functional impairment in instrumental activities of daily living: an early clinical sign of dementia? J Am Geriatr Soc. 1999;47:456-62. [PMID: 10203122]
61. Heun R. Validity of family history diagnosis for dementia [Letter]. Genet Epidemiol. 1999;17:151-4. [PMID: 10414558]
62. Lanctot KL, Best TS, Mittmann N, Liu BA, Oh PI, Einarson TR, et al. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. J Clin Psychiatry. 1998;59:550-61. [PMID: 9818639]
63. Davidson M, Weiser M, Soares K. Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: a meta-analysis of randomized controlled clinical trials. Int Psychogeriatr. 2000;12(Suppl 11):271-7.
64. Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S. Tacrine for Alzheimer's disease. Cochrane Database Syst Rev. 2000:CD000202. [PMID: 10908463]
65. Kirchner V, Kelly CA, Harvey RJ. Thioridazine for dementia. Cochrane Database Syst Rev. 2000:CD000464. [PMID: 10796547]
66. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content. Br J Psychiatry. 1990;157:72-6, 92-4. [PMID: 2397365]
67. Maurer K, Ihl R, Dierks T, Frolich L. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res. 1997;31:645-55. [PMID: 9447569]
68. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997;278: 1327-32. [PMID: 9343463]
69. Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, et al. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology. 2000;54:588-93. [PMID: 10680787]
70. Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology. 1999;53:197-201. [PMID: 10408559]
71. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000;356:2031-6. [PMID: 11145488]
72. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. 2000:CD001191. [PMID: 11034705]
73. Birks JS, Melzer D, Beppu H. Donepezil for mild and moderate Alzheimer's disease. Cochrane Database Syst Rev. 2000:CD001190. [PMID: 11034704]
74. Qizilbash N, Whitehead A, Higgins J, Wilcock G, Schneider L, Farlow M. Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration. JAMA. 1998;280:1777-82. [PMID: 9842955]
75. Olin J, Schneider L. Galantamine for Alzheimer's disease. Cochrane Database Syst Rev. 2002:CD001747. [PMID: 12137632]
76. Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, et al. Donepezil therapy in clinical practice: a randomized cross-over study. Arch Neurol. 2000;57:94-9. [PMID: 10634454]
77. Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Moller HJ, et al. The effects of donepezil in Alzheimer's disease-results from a multinational trial. Dement Geriatr Cogn Disord. 1999;10:237-44. [PMID: 10325453]
78. Rosler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ. 1999;318:633-8. [PMID: 10066203]
79. Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology. 2001;57:481-8. [PMID: 11502917]
80. Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology. 2001;57:489-95. [PMID: 11502918]
81. Ross GW, Abbott RD, Petrovitch H, Masaki KH, Murdaugh C, Trockman C, et al. Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. JAMA. 1997;277: 800-5. [PMID: 9052709]
82. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667-74. [PMID: 9385127]
83. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143-53. [PMID: 11342678]
84. Wilder D, Cross P, Chen J, Gurland B, Lantigua R, Teresi J, et al. Operating characteristics of brief screens for dementia in a multicultural population. Am J Geriatr Psychiatry. 1995;3:96-107.
85. Heun R, Papassotiropoulos A, Jennssen F. The validity of psychometric instruments for detection of dementia in the elderly general population. Int J Geriatr Psychiatry. 1998;13:368-80. [PMID: 9658272]
86. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433-41. [PMID: 1159263]
87. Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med. 1995; 122:422-9. [PMID: 7856990]
88. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15:548-61. [PMID: 10861923]
89. Kirby M, Denihan A, Bruce I, Coakley D, Lawlor BA. The clock drawing test in primary care: sensitivity in dementia detection and specificity against normal and depressed elderly. Int J Geriatr Psychiatry. 2001;16:935-40. [PMID: 11607936]
90. Scanlan JM, Brush M, Quijano C, Borson S. Comparing clock tests for dementia screening: naive judgments vs formal systems-what is optimal? Int J Geriatr Psychiatry. 2002;17:14-21. [PMID: 11802225]
91. Schramm U, Berger G, Muller R, Kratzsch T, Peters J, Frolich L. Psychometric properties of Clock Drawing Test and MMSE or Short Performance Test (SKT) in dementia screening in a memory clinic population. Int J Geriatr Psychiatry. 2002;17:254-60. [PMID: 11921154]
92. Powlishta KK, Von Dras DD, Stanford A, Carr DB, Tsering C, Miller JP, et al. The clock drawing test is a poor screen for very mild dementia. Neurology. 2002;59:898-903. [PMID: 12297574]
93. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-8. [PMID: 3611032]
94. Scanlan J, Borson S. The Mini-Cog: receiver operating characteristics with expert and naive raters. Int J Geriatr Psychiatry. 2001;16:216-22. [PMID: 11241728]
95. Frank RM, Byrne GJ. The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. Int J Geriatr Psychiatry. 2000;15:317-24. [PMID: 10767731]
96. Hogervorst E, Combrinck M, Lapuerta P, Rue J, Swales K, Budge M. The Hopkins Verbal Learning Test and screening for dementia. Dement Geriatr Cogn Disord. 2002;13:13-20. [PMID: 11731710]
97. Jarvenpaa T, Rinne JO, Raiha I, Koskenvuo M, Lopponen M, Hinkka S, et al. Characteristics of two telephone screens for cognitive impairment. Dement Geriatr Cogn Disord. 2002;13:149-55. [PMID: 11893836]
98. Lawrence J, Davidoff D, Katt-Lloyd D, Auerbach M, Hennen J. A pilot program of improved methods for community-based screening for dementia. Am J Geriatr Psychiatry. 2001;9:205-11. [PMID: 11481127]
99. Mundt JC, Ferber KL, Rizzo M, Greist JH. Computer-automated dementia screening using a touch-tone telephone. Arch Intern Med. 2001;161:2481-7. [PMID: 11700161]
100. Belle SH, Seaberg EC, Ganguli M, Ratcliff G, DeKosky S, Kuller LH. Effect of education and gender adjustment on the sensitivity and specificity of a cognitive screening battery for dementia: results from the MoVIES Project. Monongahela Valley Independent Elders Survey. Neuroepidemiology. 1996;15: 321-9. [PMID: 8930945]
101. Uhlmann RF, Larson EB. Effect of education on the mini-mental state examination as a screening test for dementia. J Am Geriatr Soc. 1991;39:876-80. [PMID: 1885862]
102. Fratiglioni L, Jorm AF, Grut M, Viitanen M, Holmen K, Ahlbom A, et al. Predicting dementia from the Mini-Mental State Examination in an elderly population: the role of education. J Clin Epidemiol. 1993;46:281-7. [PMID: 8455053]
103. Freidl W, Schmidt R, Stronegger WJ, Irmler A, Reinhart B, Koch M. Mini mental state examination: influence of sociodemographic, environmental and behavioral factors and vascular risk factors. J Clin Epidemiol. 1996;49:73-8. [PMID: 8598514]
104. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386-91. [PMID: 8479064]
105. Apolipoprotein E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer's Association Working Group. Lancet. 1996;347:1091-5. [PMID: 8602063]
106. Demers L, Oremus M, Perrault A, Wolfson C. Review of outcome measurement instruments in Alzheimer's disease drug trials: introduction. J Geriatr Psychiatry Neurol. 2000;13:161-9. [PMID: 11128056]
107. Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman J, Kramer-Ginsberg E, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry. 1994;151:390-6. [PMID: 8109647]
108. Kramer-Ginsberg E, Mohs RC, Aryan M, Lobel D, Silverman J, Davidson M, et al. Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. Psychopharmacol Bull. 1988;24:458-62. [PMID: 3153508]
109. Brooks JO 3rd, Yesavage JA, Taylor J, Friedman L, Tanke ED, Luby V, et al. Cognitive decline in Alzheimer's disease: elaborating on the nature of the longitudinal factor structure of the Mini-Mental State Examination. Int Psychogeriatr. 1993;5:135-46. [PMID: 8292767]
110. Salmon DP, Thal LJ, Butters N, Heindel WC. Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology. 1990;40:1225-30. [PMID: 2381530]
111. Peripheral and Central Nervous System Drugs Advisory Committee Meeting. 17 July 1989. Document no. 227. Rockville, MD: Department of Health and Human Services, Public Health Service, U.S. Food and Drug Administration; 1989.
112. Roman GC. Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am. 2002;86:477-99. [PMID: 12168556]
113. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002;359: 1283-90. [PMID: 11965273]
114. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288:1475-83. [PMID: 12243634]
115. Tappen RM. The effect of skill training on functional abilities of nursing home residents with dementia. Res Nurs Health. 1994;17:159-65. [PMID: 8184127]
116. Mittelman MS, Ferris SH, Steinberg G, Shulman E, Mackell JA, Ambinder A, et al. An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers. Gerontologist. 1993;33:730-40. [PMID: 8314099]
117. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397-405. [PMID: 11255443]
118. Drickamer MA, Lachs MS. Should patients with Alzheimer's disease be told their diagnosis? N Engl J Med. 1992;326:947-51. [PMID: 1542346]
119. Jha A, Tabet N, Orrell M. To tell or not to tell-comparison of older patients' reaction to their diagnosis of dementia and depression. Int J Geriatr Psychiatry. 2001;16:879-85. [PMID: 11571768]